EUVIMEDEUVIMED entdecken
Crossref

Functional insulin aspart/insulin degludec-based microneedles for promoting postprandial glycemic control

Bo Zhi Chen, Wen Xuan Li, Yun Hao Feng, Xiao Peng Zhang, Jie Jiao, Zhuo Lin Li, Vahideh Nosrati-Siahmazgi, Mohammad-Ali Shahbazi, Xin Dong Guo

Acta Biomaterialia · 2023

DOI: 10.1016/j.actbio.2023.09.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023. Verfasst von Bo Zhi Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing 100029, China; Beijing Laboratory of Biomedi…. Hauptthemen laut MEDLINE: Insulin Aspart, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Ministry of Finance, Fundamental Research Funds for the Central Universities, Rijksuniversiteit Groningen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin aspart (IAsp) and insulin degludec (IDeg), as the third generation of insulin, have a faster onset time or a more durable action period, which may simulate the secretion of insulin under physiological conditions. Microneedles (MNs) are transdermal delivery devices that may allow diabetic patients to easily deploy transdermal insulin therapy while considerably reducing injection pain. In this study, we investigated the combination of dissolving MNs with IAsp or IDeg therapy as an alternative to daily multiple insulin injections, aiming to improve glycemic control and patient compliance. Mechanical properties of the MNs, structural stability of insulin encapsulated in the MNs, and transdermal application characteristics were studied to assess the practicality of insulin-loaded MNs for diabetes therapy. In vivo experiments conducted on diabetic rats demonstrated that the IAsp- and IDeg-loaded MNs have comparable blood glucose control abilities to that of subcutaneous injections. In addition, the therapeutic properties of insulin-loaded MNs under diverse dietary conditions and application strategies were further investigated to provide new information to support future clinical trials. Taken together, the proposed MNs have the potential to improve balances between glycemic control, hypoglycemia risk, and convenience, providing patients with simpler regimens. STATEMENT OF SIGNIFICANCE: 1. The fabricated functional insulin-loaded dissolving microneedles closely matched the glucose rise that occurs in response to meals, demonstrating promising alternatives for multiple daily insulin injections. 2. The hypoglycemic properties of insulin microneedles were investigated under diverse dietary conditions and application strategies, yielding new information to support future clinical trials. 3. Molecular dynamics simulations were utilized to study the interactions between the insulin and microneedle matrix materials, providing a strategy for theoretically understanding drug stability as well as the release mechanism of drug-loaded microneedles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin AspartDiabetes Mellitus, ExperimentalHumansRatsAnimalsGlycemic ControlHypoglycemic AgentsInsulinBlood GlucoseInsulin, Long-Acting

Stichwörter der Autor:innen

DiabetesGlycemic controlInsulin aspartInsulin degludecMicroneedles

Substanzen

Insulin AspartHypoglycemic AgentsInsulinBlood Glucoseinsulin degludecInsulin, Long-Acting

Autor:innen und Institutionen

  • State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing 100029, China; Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing U…
  • Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China; Institute of Biopharmaceutical and Health Engineering, Shenzhen…
  • Department of Pharmaceutical Biomaterials, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Department of Biomedical Engineering, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands; W.J. Kolff Institute for Biomedical Engineering and Materia…

Förderung

  • Ministry of Finance
  • Fundamental Research Funds for the Central Universities
  • Rijksuniversiteit Groningen
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Ministry of Education

Zitieren

APA

Chen, B. Z., Li, W. X., Feng, Y. H., Zhang, X. P., Jiao, J., Li, Z. L., Nosrati-Siahmazgi, V., Shahbazi, M. A., & Guo, X. D. (2023). Functional insulin aspart/insulin degludec-based microneedles for promoting postprandial glycemic control. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2023.09.010

Vancouver

Chen BZ, Li WX, Feng YH, Zhang XP, Jiao J, Li ZL, et al. Functional insulin aspart/insulin degludec-based microneedles for promoting postprandial glycemic control. Acta Biomaterialia. 2023. doi:10.1016/j.actbio.2023.09.010

BibTeX
@article{Chen2023,
  author = {Chen, Bo Zhi and Li, Wen Xuan and Feng, Yun Hao and Zhang, Xiao Peng and Jiao, Jie and Li, Zhuo Lin and Nosrati-Siahmazgi, Vahideh and Shahbazi, Mohammad-Ali and Guo, Xin Dong},
  title = {Functional insulin aspart/insulin degludec-based microneedles for promoting postprandial glycemic control},
  journal = {Acta Biomaterialia},
  year = {2023},
  doi = {10.1016/j.actbio.2023.09.010}
}
Kostenlos starten →